Join the Lab

As of October 12, 2021 Dr. Amy Janes has joined the Intramural Research Program at the  National Institute on Drug Abuse. If you are interested in joining her lab at NIDA please contact Dr. Janes at Amy.janes@nih.gov

POSTDOCTORAL RESEARCH FELLOW

COGNITIVE NEUROSCIENCE/HUMAN DRUG ABUSE

The National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP) is recruiting a postdoctoral fellow to join an interdisciplinary team of scientists and physicians studying the neurobiological mechanisms of human drug abuse, comorbid addiction with psychiatric illness and their interaction with cognitive and affective processes. Multi-modal MRI (e.g. BOLD activation, resting connectivity, DTI, MRS) is used to study the mechanisms of action of nicotine, its effects on cognitive and affective processes, and how pre-existing psychiatric illness may influence nicotine‚Äôs pharmacological impact.

The ideal candidate will have a Ph.D. or M.D. and a strong research background in cognitive neuroscience, functional imaging, neurobiology of addiction and/or severe mental illness. The position offers excellent training in all aspects of functional and anatomical MRI and MR physics in a highly interactive research environment. The candidate will primarily participate in a collaborative, extramurally funded imaging project and thus have the opportunity to be jointly trained by extramural and intramural mentors. A 3 Tesla MRI is available for full-time research. Send a CV, statement of research background and interests, and arrange for 3 letters of recommendation to be sent to:

Amy C. Janes, Ph.D.,

Chief, Cognitive and Pharmacological Neuroimaging Unit NIDA-IRP, 251 Bayview Blvd, Suite 200

Baltimore, MD 21224.

OR

Email: amy.janes@nih.gov

Review of applications will begin in late November 2020 and continue until the position is filled. 

For additional information, you may contact: Rayfield YarbroughProgram Specialist, NIDA, Rayfield.Yarbrough@nih.gov

The NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities.